Physician Profile

John A. Taylor, M.D., M.S.

Associate Professor of Surgery, Division of Urology
Chairman, Cancer Committee
Director, Urology Research
Overview:

Dr. Taylor received his B.A. in biology from Lafayette College in 1990 and his M.D. from Columbia University College of Physicians & Surgeons in 1994. He completed his surgical training at the Squire Urological Clinic of Columbia University’s Presbyterian Medical Center in 2000. A commissioned officer in the United States Navy (LCDR) since 1990, he served on active duty as a staff urologist at Walter Reed Army Medical Center and Assistant Professor of Surgery at the Uniformed Services University of Health Science from 2000-03. While at Walter Reed he was an active investigator in the Department of Defense’s Center for Prostate Disease Research. Dr. Taylor has been board certified in urology since 2002 and recertified in 2011. He completed a Masters of Science Degree in Clinical and Translational Medicine at the University of Connecticut. He is a member of the American Urological Association (AUA), the American Association for Cancer Research (AACR), the Society of Urologic Oncology (SUO), the Society for Basic Urologic Research (SBUR) and serves on the national think tank for the Bladder Cancer Advocacy Network (BCAN). He is the Director of The Leo & Anne Albert Insitute for Bladder Cancer Care and Research. He has authored many publications as well as contributed to book chapters. He has been the recipient of the Dennis W. Jahnigen Scholars award administered by the American Geriatrics Society and the AUA’s post residency research award, and is currently supported by the American Cancer Society for his work in aging and bladder cancer. Dr. Taylor has extensive training in urologic cancer surgery and urinary tract reconstruction. Dr. Taylor's practice focuses on the care and treatment of bladder cancer, and complex urinary tract reconstruction.

Office Locations:

Urology
UConn Health
Outpatient Pavilion, 3rd Floor East
263 Farmington Avenue
Farmington, CT 06030
860-679-4100
Directions

Board Certifications:
  • Urology
Education and Training:
TrainingInstitutionMajor/Specialty
Undergraduate SchoolLafayette CollegeBiology
Medical SchoolColumbia University College of Physicians and SurgeonsMedicine
Graduate SchoolUniversity of ConnecticutClinical and Translational Research
InternshipColumbia Presbyterian Medical CenterGeneral Surgery
ResidencyColumbia Presbyterian Medical CenterUrology
ResidencyColumbia Presbyterian Medical CenterGeneral Surgery
Hospital Affiliation:
  • John Dempsey Hospital
Clinical Interests:

Dr. Taylors practice is focused on bringing the most advanced and up to date care for patients with bladder cancer. He is part of several international groups working toward standardization of care.

Research Interests:

Dr. Taylor has an active lab and has been funded by the American Cancer Society, American Urological Association, American Geriatrics Society and the Connecticut Institute for Clinical and Translational Science for his work in bladder cancer. His work focuses on the role of inflammation and immune response in the development of high grade bladder cancer. He currently holds 1 patent and a provisional patent for research related discoveries.

Selected Publications:


Peer Reviewed Publications

Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer. Kamat, Ashish M; Flaig, Thomas W; Grossman, H Barton; Konety, Badrinath; Lamm, Donald; O'Donnell, Michael A; Uchio, Edward; Efstathiou, Jason A; Taylor, John A. (2015). Nature reviews. Urology, 4, (12), 225-35.

Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease. Choudhary, Dharamainder; Hegde, Poornima; Voznesensky, Olga; Choudhary, Shilpa; Kopsiaftis, Stavros; Claffey, Kevin P; Pilbeam, Carol C; Taylor, John A. (2015). Urologic oncology,

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer. Kamat, Ashish M; Vlahou, Antonia; Taylor, John A; Hudson, M' Liss A; Pesch, Beate; Ingersoll, Molly A; Todenhöfer, Tilmann; van Rhijn, Bas; Kassouf, Wassim; Barton Grossman, H; Behrens, Thomas; Chandra, Ashish; Goebell, Peter J; Palou, Juan; Sanchez-Carbayo, Marta; Schmitz-Dräger, Bernd J. (2014). Urologic oncology, 7, (32), 1069-77.

Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer. Lin-Tsai, Opal; Taylor, John A; Clark, Peter E; Adam, Rosalyn M; Wu, Xue-Ru; DeGraff, David J. (2014). Current opinion in urology, 5, (24), 512-6.

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer. Schmitz-Dräger, Bernd J; Todenhöfer, Tilman; van Rhijn, Bas; Pesch, Beate; Hudson, Mliss A; Chandra, Ashish; Ingersoll, Molly A; Kassouf, Wassim; Palou, Joan; Taylor, John; Vlahou, Antonia; Behrens, Thomas; Critelli, Rossana; Grossman, H Barton; Sanchez-Carbayo, Marta; Kamat, Ashish. (2014). Urologic oncology, 7, (32), 1061-8.